FMS European Long-Term Study
NCT00757731 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 490
Last updated 2013-07-11
Summary
Investigation of the long-term (12 months) efficacy and safety of milnacipran used in the treatment of fibromyalgia syndrome.
Conditions
- Fibromyalgia Syndrome
Interventions
- DRUG
-
milnacipran
hard capsule
- DRUG
-
hard capsule
Sponsors & Collaborators
-
Pierre Fabre Medicament
lead INDUSTRY
Principal Investigators
-
Jaime C BRANCO, MD · HOSPITAL EGAS MONIZ, Lisboa, Portugal
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 71 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-09-30
- Primary Completion
- 2008-10-31
- Completion
- 2008-10-31
Countries
- Czechia
- Finland
- France
- Germany
- Italy
- Norway
- Portugal
- Romania
- Spain
- Sweden
Study Locations
More Related Trials
-
Study of Milnacipran for the Treatment of Fibromyalgia
NCT00098124 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Pain Associated With Fibromyalgia
NCT02187471 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Milnacipran Added to Pregabalin for Treatment of Fibromyalgia
NCT00797797 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Effects of Milnacipran on Pain Processing and Functional MRI in Patients With Fibromyalgia
NCT01173055 ·Status: COMPLETED ·Phase: PHASE4
-
Treatment of Pain Associated With Fibromyalgia
NCT02187159 ·Status: COMPLETED ·Phase: PHASE3
-
The Effects of Milnacipran on Sleep Disturbance in Fibromyalgia
NCT01234675 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Milnacipran on Pain Processing and Functional Magnetic Resonance Imaging (fMRI) Activation Patterns in Patients With Fibromyalgia
NCT00793520 ·Status: TERMINATED ·Phase: PHASE3
-
Milnacipran and Neurocognition, Pain and Fatigue in Fibromyalgia : A 13-week Randomized, Placebo Controlled Cross Over Trial
NCT01829243 ·Status: COMPLETED ·Phase: PHASE3
-
Study of the Symptomatic Improvement in Patients With Fibromyalgia by Means of a Food Supplement
NCT05718908 ·Status: COMPLETED
-
Effect of Milnacipran on Pain in Fibromyalgia
NCT01288807 ·Status: COMPLETED ·Phase: PHASE4
-
Discontinuation Study of the Durability of Effect of Milnacipran for the Treatment of Fibromyalgia
NCT01014585 ·Status: COMPLETED ·Phase: PHASE4
-
Randomized, Double-Blind, Placebo-Controlled Study Of Pregabalin In Patients With Fibromyalgia
NCT00830167 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Milnacipran in the Treatment of Fibromyalgia in an Elderly Population
NCT01418651 ·Status: TERMINATED ·Phase: PHASE3
-
The Effect of Milnacipran in Patients With Fibromyalgia
NCT01108731 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study for Adult Patients With Fibromyalgia
NCT00965081 ·Status: COMPLETED ·Phase: PHASE4
-
An fMRI Study Of Brain Response In Patients With Fibromyalgia
NCT00760474 ·Status: COMPLETED ·Phase: PHASE1
-
The Use of Rotigotine for Treatment of Reducing Signs and Symptoms of Fibromyalgia in Adults.
NCT00464737 ·Status: COMPLETED ·Phase: PHASE2
-
Long-Term Safety and Efficacy Study of Milnacipran in Pediatric Patients With Primary Fibromyalgia
NCT01331109 ·Status: TERMINATED ·Phase: PHASE2
-
Effects of Milnacipran on Widespread Mechanical and Thermal Hyperalgesia of Fibromyalgia Patients
NCT01294059 ·Status: COMPLETED ·Phase: PHASE1
-
The Multidisciplinary Treatment of Fibromyalgia.
NCT03673553 ·Status: COMPLETED
-
Newer Antidepressants in Combination With Pregabalin for Fibromyalgia Syndrome
NCT02451475 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Improving Quality of Life of Fibromyalgia Patients
NCT00715195 ·Status: COMPLETED ·Phase: NA
-
Fibromyalgia Study In Adults
NCT00256893 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Eslicarbazepine Acetate as Therapy in Subjects With Fibromyalgia
NCT01820585 ·Status: COMPLETED ·Phase: PHASE2
-
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
NCT01271933 ·Status: COMPLETED ·Phase: PHASE3